Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
All
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
Novo REPAIR Impact Fund is open for EU proposals: 10 May 2019 deadline
9 April 2019
Dear All: The Novo REPAIR Impact Fund is open for its second round of EU-based proposals! Four projects have been funded ...
Read More >
Duration of antibiotic dosing in veterinary medicine / Follow-up comment on FDA AMDAC on IM Bacitracin
1 April 2019
Addendum: This is the second in a series of newsletters on IM bacitracin. Go here for the prior newsletter and ...
Read More >
12 July 2019 FDA public meeting for comments on the 2018 LPAD guidance
1 April 2019
Dear All: Apologies for the back-to-back emails, but this one just came across the transom. In brief, FDA will hold a ...
Read More >
Mandatory reading: Alan Carr’s in-depth review of the antibiotic landscape
30 March 2019
Dear All: Alan Carr (acarr@needhamco.com, Needham & Company, LLC) writes a superb investment-focused newsletter focused on the antibiotic sector. We ...
Read More >
FDA Antimicrobial Drugs Advisory Committee (AMDAC) on 26 Apr 2019: IM Bacitracin for staphylococcal pneumonia and empyema in infants?!
25 March 2019
Addendum: This is the first of a series of newsletters on IM bacitracin. Go here for the next newsletter. Dear ...
Read More >
IDSA’s 10×20 could be 20×20 and yet not enough! / Harvard course on FDA and prescription drugs
22 March 2019
Dear All: Two things on a Friday: First, I just learned of IDSA’s release of its latest paper (link) in the ...
Read More >
Funding, Filing, and Finance: Most current update of this lecture
19 March 2019
Dear All: I had the opportunity today to share an updated version of my “Funding, Filing, and Finance” talk with ...
Read More >
Full-time role at Wellcome Trust: Science Innovation Lead for the Drug-Resistant Infections program
17 March 2019
Dear All: Wellcome Trust (WT) is seeking a Science Lead for WT’s Drug-Resistant Program (DRI) programme. This is a very senior role ...
Read More >
Pipelines & scorecards: Perspectives from Pew, JPIAMR, and Access to Medicine Foundation
15 March 2019
Dear All: Today we have a new pipeline summary from the Pew Trusts and news about important global scorecards from ...
Read More >
FDA workshop: Clinical trial designs for agents for non-tuberculous mycobacterial infection on 8 Apr 2019
4 March 2019
REDear All: I just heard to today that FDA is holding a public workshop entitled “Development of Antibacterial Drugs for ...
Read More >
Great job opportunity in Boston: CARB-X seeks an additional Director of R&D
27 February 2019
Dear All: CARB-X is looking for you! This new job was just now posted: The Director of R&D is a new senior role ...
Read More >
FDA in India / Longitude Prize events / NIAID seeks vaccines & therapeutics for AMR
26 February 2019
Dear All: Here’s a potpourri today of several new entries in the forward meetings list below my signature. First, the US FDA ...
Read More >
Modeling the value of an effective antibiotic — Megiddo et al.
17 February 2019
Dear All: I have previously written about the challenge of applying health technology assessment (HTA) to estimate the monetary value of an ...
Read More >
NIAID seeks your comments as it updates its strategic research framework
8 February 2019
Dear All: In 2014, NIAID set out a 5-year strategic framework for research on Antimicrobial Resistance (download it here). That document laid out ...
Read More >
Let’s make a pull incentive happen in the US during the 116th Congress!
7 February 2019
Dear All: I’ve written a lot about the need for pull incentives, preferably delinked (some papers to read, comments by TATFAR, highlights ...
Read More >
Short-term WHO role to support analysis of pre-clinical pipeline
6 February 2019
Dear All: I wrote previously (link to newsletter) about WHO’s call for information about pre-clinical antibiotic R&D. With a due ...
Read More >
Read, watch, learn, & share: Excellent BBC documentary, CID 10×20 update, BARDA director interview
6 February 2019
Dear All: Great stuff to read, watch, and share! First, there is an excellent new BBC documentary entitled The Truth About ...
Read More >
NDM-1 in the Arctic / IACG seeks your views!
30 January 2019
Dear All: Apologies for inundating with updates … the last few days have been very data rich! In case you ...
Read More >
WHO wants to hear from all pre-clinical antibiotic developers (18 Mar 2019 deadline)
29 January 2019
Dear All: Are you doing preclinical antibiotic R&D? If so, WHO wants to hear from you! As you know, WHO ...
Read More >
Draft EMA antibacterial guidance: Analysis
25 January 2019
Dear All: I wrote previously that EMA posted an extensively updated and consolidated version of their previously separate Guideline (CPMP/EWP/558/95 Rev.2) and ...
Read More >